The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Hemostatic Agents Market During 2026–2030?
The hemostatic agents market has demonstrated robust expansion in recent years. It is forecast to increase from $4.42 billion in 2025 to $4.66 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.4%. The historical development of this market can be attributed to a restricted range of hemostatic agents, a reliance on conventional thrombin and gelatin products, a rising volume of surgical procedures, expanding hospital infrastructure, and enhanced awareness regarding blood loss management.
The hemostatic agents market size is projected to undergo significant expansion in the coming years, with its value expected to reach $5.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to factors such as the innovation of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgical procedures, a rising need for multi-agent and combination hemostats, their increased application in plastic and neurosurgery, and a stronger regulatory emphasis on sterility and biocompatibility. Prominent trends throughout this period include an escalating demand for advanced hemostatic agents in surgical contexts, a growing adoption of combination and multi-agent hemostats, the expansion of fibrin sealants and biologically derived products, wider utilization of hemostats in trauma and cardiovascular surgeries, and an intensified focus on safety, sterility, and regulatory adherence.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp
Which Primary Drivers Are Impacting The Hemostatic Agents Market Growth?
The future expansion of the hemostatic agents market is anticipated to be propelled by the rising volume of surgical procedures. Surgical procedures are medical interventions performed by healthcare professionals using specialized instruments to address, repair, or remove parts of the body for health-related purposes. This increase in operations largely stems from the growing prevalence of chronic conditions, often necessitating surgical solutions to manage health problems and enhance patient recovery. Hemostatic agents play a crucial role during surgeries by rapidly arresting bleeding, thereby minimizing blood loss and enhancing surgical field clarity for precise execution. For example, in October 2025, data compiled by the UK Health Security Agency (UKHSA), a UK-based national government public health agency, from the 2023–24 period revealed that 135,619 operations were reported, with 1,276 surgical site infections (SSIs) detected during inpatient stays or upon readmission. This figure marked an 8.4% increase in submissions compared to the prior year. Consequently, the expanding number of surgical procedures is a significant driver of the hemostatic agents market’s growth.
How Are Different Segments Classified In The Hemostatic Agents Market Segment Analysis?
The hemostatic agents market covered in this report is segmented –
1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types
2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications
3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users
Subsegments:
1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products
2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin
3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches
4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents
5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations
6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials
7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats
Which Trends Are Shaping Growth In The Hemostatic Agents Market?
Leading companies active in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to provide swift and effective hemostasis and tissue closure for both open and minimally invasive surgical procedures. Collagen-based hemostats are hemostatic materials derived from purified collagen that assist in stopping bleeding by augmenting the body’s natural clotting process at the location of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, unveiled HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad. This advanced collagen-based pad integrates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, allowing for rapid sealing of bleeding sites. It offers strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less efficacious. The patch achieves hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be kept at room temperature for up to three years, addressing crucial clinical and storage needs.
Who Are The Companies Driving Activity In The Hemostatic Agents Market?
Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.
Get The Full Hemostatic Agents Market Report:
https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report
Which Region Leads The Hemostatic Agents Market In Overall Market Size?
North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hemostatic Agents Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp
Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company
Hemostats Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report
Hematology Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Hemostasis Diagnostic Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model